Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sucrosomial iron is an innovative oral iron preparation containing ferric pyrophosphate encapsulated within a phospholipid membrane and coated with sucrose esters of fatty acids. This unique structure allows the iron to be absorbed in the gastrointestinal tract via trans-cellular, para-cellular, and M-cell pathways independently of hepcidin regulation. The formulation is gastro-resistant and designed to minimize typical side effects associated with conventional oral iron supplements such as gastric irritation and constipation. It is indicated for the treatment of iron deficiency (ID) and iron deficiency anemia (IDA), especially in patients who require improved tolerability or have difficulty absorbing traditional forms of oral iron[1][7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sucrosomial iron.